Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2012

• Publication date: July 2012
• Report size: 70 pages

Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2012 Summary GlobalData's clinical trial report, “Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2012" provides data on the Alpha- Antitrypsin Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alpha- Antitrypsin Deficiency. It includes an overview of the ...

Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2012



Summary



GlobalData's clinical trial report, “Alpha- Antitrypsin Deficiency Global Clinical Trials Review, H2, 2012" provides data on the Alpha- Antitrypsin Deficiency clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Alpha- Antitrypsin Deficiency. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Alpha- Antitrypsin Deficiency. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Scope


- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)



Reasons to buy


- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Global Drug Discovery And Development Industry

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Alpha- Antitrypsin Deficiency 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by BRIC Nations 14
Clinical Trials by G7 Nations 15
Clinical Trials in G7 Nations by Trial Status 16
Clinical Trials by E7 Nations 17
Clinical Trials in E7 Nations by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Alpha- Antitrypsin Deficiency 22
Subjects Recruited Over a Period of Time 23
Prominent Sponsors 24
Top Companies Participating in Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials 26
Prominent Drug Comparison 27
Clinical Trial Profiles 28
Clinical Trial Overview of Top Companies 28
Baxter International Inc. 28
Clinical Trial Overview of Baxter International Inc. 28
Grifols, S.A. 29
Clinical Trial Overview of Grifols, S.A. 29
F. Hoffmann-La Roche Ltd. 30
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 30
Kamada Ltd. 31
Clinical Trial Overview of Kamada Ltd. 31
CSL Limited 32
Clinical Trial Overview of CSL Limited 32
Bayer AG 33
Clinical Trial Overview of Bayer AG 33
Clinical Trial Overview of Top Universities / Institutes / Hospitals 34
Medical University of South Carolina 34
Clinical Trial Overview of Medical University of South Carolina 34
University of Florida 35
Clinical Trial Overview of University of Florida 35
University of Massachusetts 36
Clinical Trial Overview of University of Massachusetts 36
Klinikum Berchtesgadener Land der Schon-Kliniken 37
Clinical Trial Overview of Klinikum Berchtesgadener Land der Schon-Kliniken 37
Hospices Civils de Lyon 38
Clinical Trial Overview of Hospices Civils de Lyon 38
Assistance Publique - Hopitaux de Paris 39
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 39
University of Pittsburgh 40
Clinical Trial Overview of University of Pittsburgh 40
Five Key Clinical Profiles 41
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 70

List of Tables

Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Zone, 2012* 7
Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2012* 10
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 11
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, North America, Top Countries, 2012* 12
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 13
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, BRIC Countries, 2012* 14
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, G7 Countries, 2012* 15
Alpha- Antitrypsin Deficiency Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, E7 Countries, 2012* 17
Alpha- Antitrypsin Deficiency Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 18
Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Phase, 2012* 19
Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 20
Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21
Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Terminated Clinical Trials, 2012* 22
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 23
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 25
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 26
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 27
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2012* 28
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2012* 29
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 30
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Kamada Ltd., 2012* 31
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2012* 32
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012* 33
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of South Carolina, 2012* 34
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Florida, 2012* 35
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2012* 36
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Klinikum Berchtesgadener Land der Schon-Kliniken, 2012* 37
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Hospices Civils de Lyon, 2012* 38
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012* 39
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2012* 40

List of Figures

Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 7
Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 8
Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 9
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2012* 10
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 11
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 12
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, G7 Countries (%), 2012* 15
Alpha- Antitrypsin Deficiency Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 16
Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 19
Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 20
Alpha- Antitrypsin Deficiency Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 21
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 23
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 24
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 26
Alpha- Antitrypsin Deficiency Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 27
GlobalData Methodology 68